Laquinimod
Attached is Teva's press release. Little detail of the actual reesults. Although it's an oral drug, FTY720 looks like it will be the gold standard for MS oral treatments in the future.
Ian
http://www.tevapharm.com/pr/2006/pr_631.asp
Ian
http://www.tevapharm.com/pr/2006/pr_631.asp